Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
about
Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptorsC-reactive protein: a critical updateVon Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination SurveyPotential role of ultrafine particles in associations between airborne particle mass and cardiovascular health.Coagulability in obstructive sleep apneaThe prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceFactoring in Factor VIII With Acute Ischemic StrokePeriodontal disease and biomarkers related to cardiovascular diseaseRole of C-reactive protein in cardiovascular diseaseReduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factorOpportunities for the treatment of inflammation in cardiovascular diseaseEndothelial dysfunction: a comprehensive appraisal.Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP studyHypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapyHypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivoConcentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteersLuteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.Recent advances in ischaemic heart disease.Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease.Do HMG-CoA reductase inhibitors affect fibrinogen?Procoagulant factors and the risk of myocardial infarction in young women.The role of von Willebrand factor in hemorrhagic and thrombotic disorders.Targeting von Willebrand factor and platelet glycoprotein Ib receptor.Temperature, air pollution, and mortality from myocardial infarction in São Paulo, Brazil.Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.Inflammation, the acute phase response and atherosclerosis.vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology.Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor.Pleiotropic functions of plasminogen activator inhibitor-1.Testing for endothelial dysfunction.Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis?Lipoprotein (a) and strokeNonvalvular atrial fibrillation: evidence for a prothrombotic state.Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation
P2860
Q24297022-AEF5C0A2-2324-480E-9099-5E96C6BAF4E2Q24672855-432EA2EC-41EC-4F7B-9F23-1B5E9758982CQ24796737-7374EC36-5E45-43B7-9943-9B59E9092440Q24813777-E963AFE3-B9E2-41D4-B347-CAE55C77FA3FQ24815147-E419D61C-CB4B-438C-AD61-0DACDA1F357FQ26830210-693A9223-A8CE-4939-A139-1CC91E5CD0AEQ27003277-EA746ABA-F680-456F-940B-404E44FD73D0Q28087052-C3B2B368-6C67-423C-A39E-AA0031B977A5Q28166908-FE42E9D2-0E05-4795-8C0E-AAA5438094E4Q28166927-F5D53EC6-0647-4B8C-AE21-640734C276D8Q28167780-93AEC5CE-D0CE-40C2-92AD-31403EB46136Q28192292-6AE9554A-BF95-4B7E-B6BD-60EFC7D46F6AQ28195411-BD8D92D1-13AA-4EEE-890C-5E7CD688AA84Q28217545-4A489D63-65A2-46DE-BF79-B927A27369CDQ28221437-EDD61265-5FA2-4DA1-9525-E0676CF5F1EEQ28343977-E7AA1811-EEAF-47DF-83B1-6773EC58C8B6Q29618549-2C14923A-B342-474B-8A07-9691861E37DAQ30300978-D833C21C-A78E-4299-ACC0-826CDFA89AB0Q30475959-9C3322AC-34C4-4B98-8DD4-CD1062B70AC5Q30590837-BFDB068F-B942-4118-A7F5-479E19C4F02AQ30912640-A9670057-71AD-4780-80B4-3BB8B89D691BQ31898591-17E6E14B-C988-4FD6-8022-0E43687CCC6AQ32052986-44DF56B5-EFBD-4285-B82A-D5CE5DEF4FDDQ33370819-B24F595D-76C8-4C06-B0DD-5A4465312CD2Q33374578-9389AD93-21BC-4F0F-8E38-5DFECE9C1C3EQ33392975-818CA6C8-CF6C-4E30-BCDD-E4355051AD1AQ33432410-7B2F8125-2EA5-4620-AA8F-3E419632A0E3Q33683302-7E7E54A6-1978-4BAC-9902-0FE9B7146131Q33694694-965C814C-320C-4E3D-A41E-B7205980B7B7Q33751790-304C2ABD-F1F6-4B78-9704-F423408D02D8Q33798485-AC65FBD4-AE45-498F-9A07-F42895E6B100Q33861058-89A06CAD-D174-409F-9497-FA1B0C629600Q33865037-D27EFBEB-7355-4A3F-8746-85F71870D410Q33912517-EB933B7E-A659-4A0E-836C-0676DC9C2146Q33984228-936B737E-BFC5-4215-9F56-A676BB6C3BE6Q34008359-E9462DCC-C65B-45FF-B7C4-5AC7E05F6DB5Q34013203-9EC619F4-937D-4273-A009-C30AE0C54D35Q34015050-C6E7918E-6D37-4B03-B798-53ABA28B3ACBQ34025550-DB2124D9-D958-40A7-B390-3D89B5E75D44Q34025555-851BB6FC-1309-492A-BD78-E502B953CF2B
P2860
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Hemostatic factors and the ris ...... s Angina Pectoris Study Group.
@en
Hemostatic factors and the ris ...... s Angina Pectoris Study Group.
@nl
type
label
Hemostatic factors and the ris ...... s Angina Pectoris Study Group.
@en
Hemostatic factors and the ris ...... s Angina Pectoris Study Group.
@nl
prefLabel
Hemostatic factors and the ris ...... s Angina Pectoris Study Group.
@en
Hemostatic factors and the ris ...... s Angina Pectoris Study Group.
@nl
P2093
P921
P1476
Hemostatic factors and the ris ...... s Angina Pectoris Study Group.
@en
P2093
Haverkate F
Thompson SG
van de Loo JC
P304
P356
10.1056/NEJM199503093321003
P407
P577
1995-03-01T00:00:00Z